Literature DB >> 31786478

Procoagulant imbalance in preterm neonates detected by thrombin generation procedures.

Armando Tripodi1, Genny Raffaeli2, Erica Scalambrino3, Lidia Padovan3, Marigrazia Clerici3, Veena Chantarangkul3, Giacomo Cavallaro2, Flora Peyvandi4, Fabio Mosca5, Stefano Ghirardello2.   

Abstract

Preterm newborns are considered at risk of acquired coagulopathy and are often prophylactically infused with fresh frozen plasma (FFP) even in the absence of bleeding. To assess the coagulation asset of preterm neonates and the biological plausibility of such infusions, we investigated at birth 87 very low birth weight (≤1500 g) preterm (gestational age <35 weeks) newborns and 64 full-term newborns. Preterm neonates were also investigated at different time-points up to 30 days after birth. Plasma from preterm and full-term neonates were subjected to the measurement of prothrombin and activated partial thromboplastin time (PT, APTT), pro- and anticoagulant factors as well as to thrombin-generation procedures both with and without thrombomodulin. PT and APTT of preterm newborns were longer than those of full-term neonates [PT: 15.9 s (11.7-51.2)-vs-13.8 (11.0-25.4), p < 0.001. APTT: 59.0 (37.8-97.5)-vs- 47.3 (28.1-71.9), p < 0.001] and tended to shortening after 30 days from birth. Thrombin-generation defined as endogenous thrombin potential (ETP) was increased in preterm as compared to full-term neonates at birth [1322 nM·min (474-2384)-vs-1006 (697-1612), p < 0.001] and did not change appreciably over time up to 30 days from birth. In conclusion, plasma from preterm neonates displays a procoagulant imbalance at birth as shown by increasing ETP, despite the prolongation of PT and APTT. The results define preterm newborns as having hyper- rather than hypo-coagulability and argue against the infusion of FFP when given prophylactically and/or based solely on prolongation of PT or APTT.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31786478     DOI: 10.1016/j.thromres.2019.11.013

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  6 in total

Review 1.  Hemostatic Testing in Critically Ill Infants and Children.

Authors:  Alison B Nair; Robert I Parker
Journal:  Front Pediatr       Date:  2021-01-08       Impact factor: 3.418

Review 2.  Neonatal respiratory and cardiac ECMO in Europe.

Authors:  Ilaria Amodeo; Matteo Di Nardo; Genny Raffaeli; Shady Kamel; Francesco Macchini; Antonio Amodeo; Fabio Mosca; Giacomo Cavallaro
Journal:  Eur J Pediatr       Date:  2021-02-05       Impact factor: 3.183

3.  Optimizing fresh-frozen plasma transfusion in surgical neonates through thromboelastography: a quality improvement study.

Authors:  Genny Raffaeli; Nicola Pesenti; Giacomo Cavallaro; Valeria Cortesi; Francesca Manzoni; Giacomo Simeone Amelio; Silvia Gulden; Luisa Napolitano; Francesco Macchini; Fabio Mosca; Stefano Ghirardello
Journal:  Eur J Pediatr       Date:  2022-02-24       Impact factor: 3.860

Review 4.  Hemostasis in neonatal ECMO.

Authors:  Valeria Cortesi; Genny Raffaeli; Giacomo S Amelio; Ilaria Amodeo; Silvia Gulden; Francesca Manzoni; Gaia Cervellini; Andrea Tomaselli; Marta Colombo; Gabriella Araimo; Andrea Artoni; Stefano Ghirardello; Fabio Mosca; Giacomo Cavallaro
Journal:  Front Pediatr       Date:  2022-08-26       Impact factor: 3.569

5.  Editorial: Neonatal ECMO in 2019: Where Are We Now? Where Next?

Authors:  Giacomo Cavallaro; Matteo Di Nardo; Aparna Hoskote; Dick Tibboel
Journal:  Front Pediatr       Date:  2022-01-04       Impact factor: 3.418

Review 6.  The role of the calibrated automated thrombogram in neonates: describing mechanisms of neonatal haemostasis and evaluating haemostatic drugs.

Authors:  Claire A Murphy; Elaine Neary; Daniel P O'Reilly; Sarah Cullivan; Afif El-Khuffash; Fionnuala NíAinle; Patricia B Maguire; Naomi McCallion; Barry Kevane
Journal:  Eur J Pediatr       Date:  2021-07-20       Impact factor: 3.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.